• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Alternative breast imaging undergoes scrutiny

Article

Researchers at Dartmouth Medical School are experimenting with three promising new electromagnetic imaging techniques to help detect breast abnormalities. The team examined electrical impedance spectroscopy, microwave imaging spectroscopy, and

Researchers at Dartmouth Medical School are experimenting with three promising new electromagnetic imaging techniques to help detect breast abnormalities. The team examined electrical impedance spectroscopy, microwave imaging spectroscopy, and near-infrared spectroscopy. These technologies use low-frequency electrical currents, microwaves, and infrared light, respectively, to create computerized cross sections of the breast. The differing properties addressed by these technologies promise to help identify specific breast characteristics that differ in normal and diseased tissue. Once the researchers establish normal ranges for specific breast characteristics, they will try to identify data patterns that indicate abnormalities, including cancer. The research is part of the five-year Alternative Breast Imaging Project funded by a grant from the National Cancer Institute.

Related Videos
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.